120 related articles for article (PubMed ID: 11857074)
21. The vascular network of tumours--what is it not for?
Sivridis E; Giatromanolaki A; Koukourakis MI
J Pathol; 2003 Oct; 201(2):173-80. PubMed ID: 14517833
[TBL] [Abstract][Full Text] [Related]
22. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development.
Young N; Hahn CN; Poh A; Dong C; Wilhelm D; Olsson J; Muscat GE; Parsons P; Gamble JR; Koopman P
J Natl Cancer Inst; 2006 Aug; 98(15):1060-7. PubMed ID: 16882943
[TBL] [Abstract][Full Text] [Related]
23. Modelling approaches for angiogenesis.
Taraboletti G; Giavazzi R
Eur J Cancer; 2004 Apr; 40(6):881-9. PubMed ID: 15120043
[TBL] [Abstract][Full Text] [Related]
24. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
25. Mathematical modelling of flow through vascular networks: implications for tumour-induced angiogenesis and chemotherapy strategies.
McDougall SR; Anderson AR; Chaplain MA; Sherratt JA
Bull Math Biol; 2002 Jul; 64(4):673-702. PubMed ID: 12216417
[TBL] [Abstract][Full Text] [Related]
26. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
27. [Identification of interaction partners and function analysis of new splicing product of human LMO2 gene].
Yuan W; Yang S; Sun W; Du J; Zhai CL; Wang ZQ; Zhu TH
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):325-8. PubMed ID: 18844071
[TBL] [Abstract][Full Text] [Related]
28. Are tumours angiogenesis-dependent?
Verheul HM; Voest EE; Schlingemann RO
J Pathol; 2004 Jan; 202(1):5-13. PubMed ID: 14694516
[TBL] [Abstract][Full Text] [Related]
29. The effect of chromosomal translocations in acute leukemias: the LMO2 paradigm in transcription and development.
Rabbitts TH; Bucher K; Chung G; Grutz G; Warren A; Yamada Y
Cancer Res; 1999 Apr; 59(7 Suppl):1794s-1798s. PubMed ID: 10197599
[TBL] [Abstract][Full Text] [Related]
30. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
31. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
32. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth.
Hatzi E; Murphy C; Zoephel A; Rasmussen H; Morbidelli L; Ahorn H; Kunisada K; Tontsch U; Klenk M; Yamauchi-Takihara K; Ziche M; Rofstad EK; Schweigerer L; Fotsis T
Oncogene; 2002 May; 21(22):3552-61. PubMed ID: 12032857
[TBL] [Abstract][Full Text] [Related]
33. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
34. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
35. Zebrafish scl functions independently in hematopoietic and endothelial development.
Dooley KA; Davidson AJ; Zon LI
Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
[TBL] [Abstract][Full Text] [Related]
36. The retinoid X receptor-selective ligand, LGD1069, inhibits tumor-induced angiogenesis via suppression of VEGF in human non-small cell lung cancer.
Fu J; Ding Y; Huang D; Li H; Chen X
Cancer Lett; 2007 Apr; 248(1):153-63. PubMed ID: 17027148
[TBL] [Abstract][Full Text] [Related]
37. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
38. A simple mechanistic model of sprout spacing in tumour-associated angiogenesis.
Addison-Smith B; McElwain DL; Maini PK
J Theor Biol; 2008 Jan; 250(1):1-15. PubMed ID: 18028960
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.
Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG
Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637
[TBL] [Abstract][Full Text] [Related]
40. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia.
Appert A; Nam CH; Lobato N; Priego E; Miguel RN; Blundell T; Drynan L; Sewell H; Tanaka T; Rabbitts T
Cancer Res; 2009 Jun; 69(11):4784-90. PubMed ID: 19487290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
